TECTONIC THERAPEUTIC, INC. Payments of Merger Related Costs, Financing Activities
TECTONIC THERAPEUTIC, INC. (TECX) reported Payments of Merger Related Costs, Financing Activities of $1.20 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2024-08-14
- 2024-06-30: Payments of Merger Related Costs, Financing Activities 6 month $1.20M.
| Period end | Payments of Merger Related Costs, Financing Activities 6 month |
|---|---|
| 2024-06-30 | $1.20M 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |